logo

For the Inventor, By the Inventor

Vienna, Austria

Nabriva Therapeutics Ag

Calculating rank
USPTO Granted Patents = 18

% Expired Patents = 27.8



Forward Citations = 131

Loading Chart...
Loading Chart...

22 inventors (with patents filed for the assignee):

goldMedal Werner Heilmayer (9 out of 15 patents)

silverMedal Rosemarie Mang (5 out of 6 patents)

bronzeMedal Heinz Berner (5 out of 9 patents)

4.  Klaus Thirring (4 out of 7 patents)

5.  Rosemarie Riedl (4 out of 7 patents)

6.  Atchyuta Rama Chandra Murty Bulusu (4 out of 4 patents)

7.  Gerd Ascher (4 out of 29 patents)

8.  Dirk B Strickmann (3 out of 3 patents)

9.  Johannes Hildebrandt (3 out of 7 patents)

10.  Lee Spence (2 out of 3 patents)

11.  Ingolf Macher (2 out of 2 patents)

12.  Andreas Berger (2 out of 6 patents)

13.  Rudolf Badegruber (2 out of 2 patents)

14.  Rodger Novak (2 out of 4 patents)

15.  Mathias Ferencic (2 out of 3 patents)


18 patents:

1. 9701628 - 12-epi pleuromutilins (2017-07-11),
2. 9278920 - Pleuromutilin derivatives for use in the treatment of diseases mediated by microbes (2016-03-08),
3. 9120808 - Substituted clavulanic acid (2015-09-01),
4. 9120727 - Process for the preparation of pleuromutilins (2015-09-01),
5. 9061980 - Organic compounds (2015-06-23),
6. 8987498 - Enantiomerically pure amines (2015-03-24),
7. 8624033 - Pleuromutilins and process for the preparation of pleuromutilins (2014-01-07),
8. 8343972 - Organic compounds (2013-01-01),
9. 8334389 - Process for the preparation of pleuromutilins (2012-12-18),
10. 8222447 - Organic compounds (2012-07-17),
11. 8173685 - Pleuromutilin derivatives and their use as antimicrobials (2012-05-08),
12. 8153689 - Pleuromutilin derivatives for the treatment of diseases mediated by microbes (2012-04-10),
13. 8088823 - Tuberculosis treatment using pleuromutilin derivatives (2012-01-03),
14. 8071643 - Pleuromutilin derivatives for the treatment of diseases mediated by microbes (2011-12-06),
15. 7790749 - [object Object] (2010-09-07),
Company Overview
Nabriva Therapeutics AG is a biopharmaceutical company based in Vienna, Austria, focused on the development of innovative therapies for serious infections. The company specializes in the discovery and commercialization of novel antibiotics, addressing the growing challenge of antibiotic resistance. Nabriva's research efforts are centered on advancing treatments that target both hospital-acquired and community-acquired infections, contributing to improved patient outcomes in the global healthcare landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

18 Patents

#52 in Vienna

#198 in Austria

#34,263 in the World

Vienna, AT
Vienna, Austria

Nabriva Therapeutics Ag

Forward Citations = 131

22 inventors:

goldMedal Werner Heilmayer (9 out of 15 patents)

silverMedal Rosemarie Mang (5 out of 6 patents)

bronzeMedal Heinz Berner (5 out of 9 patents)

4.  Klaus Thirring (4 out of 7 patents)

5.  Rosemarie Riedl (4 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Nabriva Therapeutics Ag. Retrieved from https://idiyas.com/company/nabriva-therapeutics-ag

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…